Skip to content

Radiogenomic analysis of infants to predict neurodevelopmental outcome

Radiogenomic analysis of infants to predict neurodevelopmental outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007275
Enrollment
100
Registered
2022-05-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria Infants who are born or anticipated to be born at 32 weeks or later and before 37 weeks of gestational age. Neonates who live within 100 km of the hospital to allow for follow-up appointments to the hospital. Eligibility criteria Infants who are born or anticipated to be born between 38 and 41 weeks gestation will be eligible for participation. The infants should be born after uncomplicated pregnancy and delivery, which will be screened by obstetricians.

Exclusion criteria

Exclusion criteria: Exclusion criteria Infants who are diagnosed with any congenital or chromosomal abnormality that could affect the neurodevelopmental outcome. Infants who are diagnosed infectious or inflammatory disease that could affect the neurodevelopmental outcome. Infants who have a contraindication to MRI. Exclusion criteria Infants who cannot undergo MRI.

Design outcomes

Primary

MeasureTime frame
Infant neurodevelopment test results

Secondary

MeasureTime frame
Infant neurodevelopment test results

Countries

Korea, Republic of

Contacts

Public ContactHyun Gi Kim

The Catholic University of Korea

catharina@catholic.ac.kr+82-2-2030-3019

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026